Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Extended Duration Varenicline for Smoking Among Cancer Patients: A Clinical Trial

NCT01756885 is registered in ClinicalTrials.gov with University of Pennsylvania as lead sponsor.

NCT NCT01756885
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01756885 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Extended Duration Varenicline for Smoking Among Cancer Patients: A Clinical Trial
Lead sponsor
University of Pennsylvania
Phase
Phase 3
Overall status
Completed
Start date
January 31, 2013
Completion date
May 31, 2018
Enrollment
207 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

nicotine dependence